Concepedia

Publication | Open Access

RAS testing and cetuximab treatment for metastatic colorectal cancer: a cost-effectiveness analysis in a setting with limited health resources

DOIFull Paper Access

33

Citations

26

References

2017

Year

Bin Wu, Yuan Yao, Ke Zhang, Xuezhen Ma
Oncotarget

Abstract

RAS testing with cetuximab treatment is likely to be cost-effective for patients with mCRC when PAP is available in China.

References

YearCitations

Page 1